Lazard Asset Management
CTIC

Lazard Asset Management’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Lazard Asset Management’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-9,894
Closed -$41K – 2639
2023
Q1 		$41K Hold
9,894
– – ﹤0.01% 1858
2022
Q4 		$59K Hold
9,894
– – ﹤0.01% 1727
2022
Q3 		$57K Buy
+9,894
New +$57K ﹤0.01% 1746